Literature DB >> 21397357

Non-return valves do not prevent backflow and bacterial contamination of intravenous infusions.

B Ellger1, D Kiski, E Diem, I van den Heuvel, H Freise, H Van Aken, F Hinder, A W Friedrich.   

Abstract

Non-return valves (NRVs) are designed to avoid backflow of infusion fluid against the designated direction of flow (DDF) when more than one infusion is delivered via one venous access. We tested in vitro whether NRVs reliably prevent flow against the DDF at clinically relevant low flow rates. Since catheter-related infections caused by the infusion of contaminated fluids represent a relevant problem in patient care, we tested whether NRVs preclude bacterial contamination of infusions proximal to the NRVs and thus might play a role in preventing healthcare-associated infections. Additionally, the incidence of bacterial contamination of drips and infusion fluids in our intensive care unit (ICU) was quantified. In vitro, a low flow against the DDF of ten examples each of five different NRV models was applied and the integrity for fluid and transmigration of three different indicator micro-organisms was tested. Second, we investigated whether contamination of intravenous infusion tubing collected from patients treated on our ICU occurred. Largely independent from the model, 40% of the tested NRVs were not leak-tight for fluids when a pressure against the DDF was built up slowly. In 30%, bacteria migrated against the DDF and were detected proximal to the valve. In 6.7% of the tubing samples collected from ICU patients we detected bacterial contamination. In conclusion, contamination of drips is a relevant problem on ICU. NRVs neither reliably prevent backflow of fluids nor serve as micro-organism filters. Therefore they cannot be recommended as a way of reducing healthcare-associated infections.
Copyright © 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21397357     DOI: 10.1016/j.jhin.2010.12.015

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  2 in total

Review 1.  Evidence-based measures to prevent central line-associated bloodstream infections: a systematic review.

Authors:  Daniele Cristina Perin; Alacoque Lorenzini Erdmann; Giovana Dorneles Callegaro Higashi; Grace Teresinha Marcon Dal Sasso
Journal:  Rev Lat Am Enfermagem       Date:  2016-09-01

2.  Fibrin Clot Mistook as a Worm in the Intravenous Line.

Authors:  Jun Hyun Kim; Ji Yeon Kim; Yeon Soo Park; Kyung Tae Kim; Sang Il Lee; Min Hee Heo
Journal:  Yonsei Med J       Date:  2020-03       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.